drugset / Trial / NCT00793858

A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray

NCT00793858 ↗

RandomizedSingle-groupSingle-blindBasic science

Summary

The purpose of this study is to measure the amount of a nasal steroid spray (ciclesonide) absorbed by the tissue in the nose 2 hours after having this study drug sprayed in the nose

Timeline

Start
2009-02
Primary completion
2009-09
Completion
—

Outcome

Outcome not reported

Stopped: “Cost prohibitive and company withdrew support.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciclesonide Other / unclassified 200 ug Intranasal

Indications